We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current N1VS34 market cap is 124.38B. The company's latest EPS is USD 7.2670 and P/E is 13.46.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.87B | 20.09B | 11.83B | 13.16B | 12.17B |
| Operating Income | 1.41B | 2.84B | 3.34B | 4.01B | 3.62B |
| Net Income | 1.76B | 8.48B | 2.69B | 3.25B | 3.19B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 50.49B | 49.9B | 52.88B | 51.83B | 54.11B |
| Operating Income | 9.82B | 10.83B | 27.03B | 9.19B | 10.02B |
| Net Income | 11.73B | 8.07B | 24.02B | 6.96B | 14.85B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 112.7B | 99.95B | 94.33B | 97.51B | 103.52B |
| Total Liabilities | 74.45B | 53.2B | 54.58B | 55.6B | 60.08B |
| Total Equity | 38.25B | 46.75B | 39.76B | 41.9B | 43.44B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 118.37B | 132.06B | 131.8B | 117.45B | 99.95B |
| Total Liabilities | 62.82B | 75.39B | 63.97B | 58.03B | 53.2B |
| Total Equity | 55.55B | 56.67B | 67.82B | 59.42B | 46.75B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 11.91B | 9.84B | 2.27B | 7.14B | 13.43B |
| Investing | 7.36B | N/A | -899M | -4.11B | -4.48B |
| Financing | -13.67B | N/A | -5.16B | -8.36B | -8.75B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 13.63B | 13.65B | 15.07B | 14.24B | 9.84B |
| Investing | -2.23B | -13.18B | 4.21B | 1.47B | N/A |
| Financing | -13.63B | -2.21B | -16.26B | -20.56B | N/A |
| Market Cap | 124.38B |
| Price to Earnings Ratio | 13.46 |
| Price to Sales Ratio | 3.69 |
| Price to Cash Ratio | 14.93 |
| Price to Book Ratio | 4.28 |
| Dividend Yield | - |
| Shares Outstanding | 2.04B |
| Average Volume (1 week) | 81 |
| Average Volume (1 Month) | 115 |
| 52 Week Change | 27.97% |
| 52 Week High | 68.54 |
| 52 Week Low | 47.50 |
| Spread (Intraday) | 27.89 (41.08%) |
| Company Name | Novartis AG |
| Address |
po box basel 4002 |
| Website | https://www.novartis.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
